These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18778484)

  • 1. Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.
    Liu H; Zhang L; Niu Z; Zhou M; Peng C; Li X; Deng T; Shi L; Tan Y; Li G
    BMC Cancer; 2008 Sep; 8():253. PubMed ID: 18778484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.
    Liu H; Zhou M; Luo X; Zhang L; Niu Z; Peng C; Ma J; Peng S; Zhou H; Xiang B; Li X; Li S; He J; Li X; Li G
    BMC Mol Biol; 2008 Dec; 9():111. PubMed ID: 19111069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of the BRD7 gene promoter.
    Liu H; Peng C; Zhou M; Zhou J; Shen S; Zhou H; Xiong W; Luo X; Peng S; Niu Z; Ouyang J; Li X; Li G
    DNA Cell Biol; 2006 Jun; 25(6):346-58. PubMed ID: 16792505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircBRD7 attenuates tumor growth and metastasis in nasopharyngeal carcinoma via epigenetic activation of its host gene.
    Wei J; Li M; Chen S; Xue C; Zheng L; Duan Y; Deng H; Fan S; Xiong W; Zhou M
    Cancer Sci; 2024 Jan; 115(1):139-154. PubMed ID: 37940358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.
    Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z
    BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Expression of BRD7-interacting proteins,BRD2 and BRD3, in nasopharyngeal carcinoma tissues].
    Zhou M; Peng C; Nie XM; Zhang BC; Zhu SG; Yu Y; Li XL; Li GY
    Ai Zheng; 2003 Feb; 22(2):123-7. PubMed ID: 12600283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRD7 promoter hypermethylation as an indicator of well differentiated oral squamous cell carcinomas.
    Balasubramanian A; Subramaniam R; Narayanan V; Annamalai T; Ramanathan A
    Asian Pac J Cancer Prev; 2015; 16(4):1615-9. PubMed ID: 25743841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways.
    Peng C; Liu HY; Zhou M; Zhang LM; Li XL; Shen SR; Li GY
    Mol Cell Biochem; 2007 Sep; 303(1-2):141-9. PubMed ID: 17458518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
    Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
    Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.
    You Y; Yang W; Wang Z; Zhu H; Li H; Lin C; Ran Y
    Cell Oncol (Dordr); 2013 Jul; 36(4):323-31. PubMed ID: 23740091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
    Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q
    Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker.
    Li J; Gong P; Lyu X; Yao K; Li X; Peng H
    Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.